 | Metacrine, Inc. (NASDAQ:MTCR) Short Interest Update
americanbankingnews.com - November 16 at 1:06 PM |
 | Form 10-Q Metacrine, Inc. For: Sep 30 - StreetInsider.com
streetinsider.com - November 12 at 5:35 PM |
 | Metacrine Reports Third-Quarter 2021 Results - Yahoo Finance
finance.yahoo.com - November 12 at 12:34 PM |
 | Metacrine Reports Third-Quarter 2021 Results - GlobeNewswire
globenewswire.com - November 11 at 12:51 PM |
| Metacrine Reports Third-Quarter 2021 Results
finance.yahoo.com - November 11 at 12:51 PM |
 | Why Eli Lilly Shares Traded Higher Today - Benzinga
benzinga.com - November 3 at 1:48 AM |
| Why Eli Lilly Shares Traded Higher Today - Yahoo Finance
finance.yahoo.com - November 2 at 8:47 PM |
| Metacrine Reports Topline Results for MET409 Phase 2a - GlobeNewswire
globenewswire.com - November 2 at 3:47 PM |
| Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
finance.yahoo.com - November 2 at 3:47 PM |
| Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH
finance.yahoo.com - November 2 at 10:46 AM |
| How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More - Benzinga
benzinga.com - October 25 at 10:57 PM |
|
| How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More - Yahoo Finance
finance.yahoo.com - October 25 at 5:56 PM |
| Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump - Yahoo Finance
finance.yahoo.com - October 22 at 5:31 PM |
 | Metacrine cut to neutral at H.C. Wainwright as company's NASH program ends - Seeking Alpha
seekingalpha.com - October 22 at 5:31 PM |
| Metacrine Reports Interim Results for MET642 Phase 2a Trial in Patients with NASH and Announces a Strategic Re-Prioritization of Its Clinical Development Programs - Yahoo Finance
finance.yahoo.com - October 22 at 5:31 PM |
| Metacrine, Inc. 8-K Oct. 21, 2021 4:06 PM - Seeking Alpha
seekingalpha.com - October 22 at 12:31 PM |
 | Pre-market Movers: PHUN, CRTD, MTCR, DWAC, SNAP… - Nasdaq
nasdaq.com - October 22 at 7:31 AM |
| Metacrine Reports Interim Results for MET642 Phase 2a Trial - GlobeNewswire
globenewswire.com - October 21 at 4:28 PM |
| Metacrine Reports Interim Results for MET642 Phase 2a Trial in Patients with NASH and Announces a Strategic Re-Prioritization of Its Clinical Development Programs
finance.yahoo.com - October 21 at 4:28 PM |
| 48 Biggest Movers From Friday - Yahoo Finance
finance.yahoo.com - September 27 at 10:44 AM |
| Leap Therapeutics, aTyr Pharma lead healthcare gainers; Silverback Therapeutics, Aerie Pharmaceuticals among major losers - Seeking Alpha
seekingalpha.com - September 16 at 12:39 PM |
| LAUR, LPTX, AERI and TWKS among after hours movers - Seeking Alpha
seekingalpha.com - September 15 at 8:48 PM |
| Metacrine dips on R&D day with high trading volume - Seeking Alpha
seekingalpha.com - September 15 at 8:48 PM |
| Candel Therapeutics Announces Presentations of Key Clinical Data at AdMeTech and European Association of Neuro-Oncology Conferences in September 2021 - Yahoo Finance
finance.yahoo.com - September 9 at 10:20 PM |
| Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash
finance.yahoo.com - September 9 at 5:11 PM |
| Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021 - Yahoo Finance
finance.yahoo.com - September 9 at 2:19 AM |
| Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021
finance.yahoo.com - September 8 at 9:14 AM |
| Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 7 at 6:13 PM |
| Form 8-K Metacrine, Inc. For: Aug 12 - StreetInsider.com
streetinsider.com - August 12 at 9:08 PM |
| Metacrine Updates MET642 Clinical Development Milestone and - GlobeNewswire
globenewswire.com - August 12 at 4:07 PM |
| Metacrine Updates MET642 Clinical Development Milestone and Reports Second-Quarter 2021 Results
finance.yahoo.com - August 12 at 4:07 PM |
| Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease (IBD) at European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress - Yahoo Finance
finance.yahoo.com - July 7 at 1:15 PM |
| Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease - GlobeNewswire
globenewswire.com - July 7 at 12:47 AM |
|
| Metacrine to Present New Preclinical Data in Inflammatory Bowel Disease (IBD) at European Crohn’s and Colitis Organisation (ECCO) 2021 Virtual Congress
finance.yahoo.com - July 6 at 9:46 AM |
| Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021 - GlobeNewswire
globenewswire.com - June 17 at 8:45 AM |
| Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021
finance.yahoo.com - June 17 at 8:45 AM |
| UPDATE: HC Wainwright Starts Metacrine Inc. (MTCR) at Buy - StreetInsider.com
streetinsider.com - June 14 at 6:51 PM |
| Metacrine initiated buy at H.C. Wainwright citing novelty in therapeutic platform - Seeking Alpha
seekingalpha.com - June 14 at 1:51 PM |
| Metacrine completes enrollment in mid-stage NASH trial
seekingalpha.com - June 4 at 2:28 PM |
| Metacrine Achieves Full Enrollment for MET409 Phase 2a - GlobeNewswire
globenewswire.com - June 2 at 9:25 AM |
| Metacrine Achieves Full Enrollment for MET409 Phase 2a Combination Trial in Patients With Type 2 Diabetes and NASH
finance.yahoo.com - June 2 at 9:25 AM |
| Metacrine to Present at 2021 Jefferies Healthcare Conference - Yahoo Finance
finance.yahoo.com - May 28 at 8:40 AM |
| Metacrine to Present at 2021 Jefferies Healthcare Conference - GlobeNewswire
globenewswire.com - May 26 at 8:11 AM |
| Metacrine to Present at 2021 Jefferies Healthcare Conference
finance.yahoo.com - May 26 at 8:11 AM |
| Did Metacrine, Inc. (NASDAQ:MTCR) Insiders Buy Up More Shares? - Yahoo Finance
finance.yahoo.com - May 22 at 2:16 PM |
| Did Metacrine, Inc. (NASDAQ:MTCR) Insiders Buy Up More Shares?
finance.yahoo.com - May 22 at 2:16 PM |
| Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings - Benzinga
benzinga.com - May 21 at 8:44 PM |
| Metacrine Inc (MTCR) President & CEO Preston Klassen Bought $74,791 of Shares - Yahoo Finance
finance.yahoo.com - May 21 at 2:07 PM |
| Metracrine rises 10.27% after hours as CMO and CEO acquires shares - Seeking Alpha
seekingalpha.com - May 21 at 9:06 AM |
| Metacrine, Inc. 4 May. 20, 2021 6:55 PM - Seeking Alpha
seekingalpha.com - May 21 at 9:06 AM |
